T cell CD62L expression following nivolumab therapy is associated with response to rituximab-nivolumab in treatment näıve follicular lymphoma: the 1st FLOR study
Journal article published in 2023 by
Rm Koldej,
A. Barraclough,
St Lee,
H. Morgan 
,
N. Holzwart,
M. Koshy,
C. Smith,
G. Chong,
M. Gilbertson,
C. Keane,
Others
,
N. Holzwart,
M. Koshy,
C. Smith,
G. Chong,
M. Gilbertson,
C. Keane,
Others
